BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,313 | -22.4% | 285 | -2.4% | 0.00% | – |
| Q2 2023 | $18,454 | +142.7% | 292 | +72.8% | 0.00% | – |
| Q1 2023 | $7,603 | +48.3% | 169 | +44.4% | 0.00% | – |
| Q4 2022 | $5,126 | -60.6% | 117 | -42.1% | 0.00% | – |
| Q3 2022 | $13,000 | 0.0% | 202 | -23.2% | 0.00% | – |
| Q2 2022 | $13,000 | +44.4% | 263 | +89.2% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 139 | +29.9% | 0.00% | – |
| Q4 2021 | $11,000 | +22.2% | 107 | +18.9% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 90 | +2.3% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 88 | +1.1% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 87 | +1.2% | 0.00% | – |
| Q4 2020 | $10,000 | +25.0% | 86 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | +60.0% | 86 | +30.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 66 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 66 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |